Back to top

Human PAI-1, Stable Mutant - stable

Product Overview

Human PAI-1 Recombinant LRP Binding Negative has been recombinantly produced in E. coli and purified by affinity chromatography. PAI-1 mutant with subsitution of Glutamic Acid for Arginine at postion 76. This greatly reduces PAI-1 binding to low density lipoprotein receptor-related protein (LRP). An additional mutation (Isoleucine 91 to Leucine) provides increased stability for long-term binding experiments.

More Details:

  • Species: Human
  • Target: PAI-1
  • Purification Method: Affinity purified
  • Purity: >95% as determined by SDS-PAGE Analysis
  • Source: E. coli
  • Storage Conditions: -20 C